Adiponectin: Its role in obesity-associated colon and prostate cancers

Santoshi Muppala, Siva K.P. Konduru, Neha Merchant, Judy Ramsoondar, Carlos Karan Rampersad, Balney Rajitha, Vidya Mukund, Jyothsna Kancherla, Anthea Hammond, Tapan Kumar Barik, Mastan Mannarapu, Afroz Alam, Riyaz Mahammad Basha, Pallaval Veera Bramhachari, Dheeraj Verma, Pinninti Santosh Sushma, Subasini Pattnaik, Ganji Purnachandra Nagaraju

Research output: Contribution to journalReview articleResearchpeer-review

12 Citations (Scopus)

Abstract

Adipose tissue synthesizes many proteins and hormones collectively called adipokines, which are linked to a number of diseases, including cancer. Low levels of adiponectin are reported to be a risk factor for obesity-related cancers including colorectal and prostate cancers. Accordingly, obesity/lifestyle-related diseases, including certain cancers, may be treated by developing drugs that act specifically on adiponectin levels in circulation. Adiponectin may also serve as a clinical biomarker in obesity-related diseases. Adiponectin-based therapies are known to inhibit cancer advancement and thus may provide a therapeutic approach to delay cancer progression. Better understanding of the function of adiponectin is of great significance in the fight against cancer. This timely review is concentrated on the role of adiponectin and the impact of obesity on the development of cancers, especially colorectal and prostate cancers.

Original languageEnglish
Pages (from-to)125-133
Number of pages9
JournalCritical Reviews in Oncology/Hematology
Volume116
DOIs
StatePublished - 1 Aug 2017

Fingerprint

Adiponectin
Colonic Neoplasms
Prostatic Neoplasms
Obesity
Neoplasms
Colorectal Neoplasms
Adipokines
Adipose Tissue
Life Style
Biomarkers
Hormones
Therapeutics
Pharmaceutical Preparations
Proteins

Keywords

  • Adiponectin
  • Adiponectin receptors
  • Colorectal cancer
  • Obesity
  • Prostate cancer

Cite this

Muppala, S., Konduru, S. K. P., Merchant, N., Ramsoondar, J., Rampersad, C. K., Rajitha, B., ... Nagaraju, G. P. (2017). Adiponectin: Its role in obesity-associated colon and prostate cancers. Critical Reviews in Oncology/Hematology, 116, 125-133. https://doi.org/10.1016/j.critrevonc.2017.06.003
Muppala, Santoshi ; Konduru, Siva K.P. ; Merchant, Neha ; Ramsoondar, Judy ; Rampersad, Carlos Karan ; Rajitha, Balney ; Mukund, Vidya ; Kancherla, Jyothsna ; Hammond, Anthea ; Barik, Tapan Kumar ; Mannarapu, Mastan ; Alam, Afroz ; Basha, Riyaz Mahammad ; Bramhachari, Pallaval Veera ; Verma, Dheeraj ; Sushma, Pinninti Santosh ; Pattnaik, Subasini ; Nagaraju, Ganji Purnachandra. / Adiponectin : Its role in obesity-associated colon and prostate cancers. In: Critical Reviews in Oncology/Hematology. 2017 ; Vol. 116. pp. 125-133.
@article{c88a003801c74e8ea6a263985e65f677,
title = "Adiponectin: Its role in obesity-associated colon and prostate cancers",
abstract = "Adipose tissue synthesizes many proteins and hormones collectively called adipokines, which are linked to a number of diseases, including cancer. Low levels of adiponectin are reported to be a risk factor for obesity-related cancers including colorectal and prostate cancers. Accordingly, obesity/lifestyle-related diseases, including certain cancers, may be treated by developing drugs that act specifically on adiponectin levels in circulation. Adiponectin may also serve as a clinical biomarker in obesity-related diseases. Adiponectin-based therapies are known to inhibit cancer advancement and thus may provide a therapeutic approach to delay cancer progression. Better understanding of the function of adiponectin is of great significance in the fight against cancer. This timely review is concentrated on the role of adiponectin and the impact of obesity on the development of cancers, especially colorectal and prostate cancers.",
keywords = "Adiponectin, Adiponectin receptors, Colorectal cancer, Obesity, Prostate cancer",
author = "Santoshi Muppala and Konduru, {Siva K.P.} and Neha Merchant and Judy Ramsoondar and Rampersad, {Carlos Karan} and Balney Rajitha and Vidya Mukund and Jyothsna Kancherla and Anthea Hammond and Barik, {Tapan Kumar} and Mastan Mannarapu and Afroz Alam and Basha, {Riyaz Mahammad} and Bramhachari, {Pallaval Veera} and Dheeraj Verma and Sushma, {Pinninti Santosh} and Subasini Pattnaik and Nagaraju, {Ganji Purnachandra}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.critrevonc.2017.06.003",
language = "English",
volume = "116",
pages = "125--133",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

Muppala, S, Konduru, SKP, Merchant, N, Ramsoondar, J, Rampersad, CK, Rajitha, B, Mukund, V, Kancherla, J, Hammond, A, Barik, TK, Mannarapu, M, Alam, A, Basha, RM, Bramhachari, PV, Verma, D, Sushma, PS, Pattnaik, S & Nagaraju, GP 2017, 'Adiponectin: Its role in obesity-associated colon and prostate cancers' Critical Reviews in Oncology/Hematology, vol. 116, pp. 125-133. https://doi.org/10.1016/j.critrevonc.2017.06.003

Adiponectin : Its role in obesity-associated colon and prostate cancers. / Muppala, Santoshi; Konduru, Siva K.P.; Merchant, Neha; Ramsoondar, Judy; Rampersad, Carlos Karan; Rajitha, Balney; Mukund, Vidya; Kancherla, Jyothsna; Hammond, Anthea; Barik, Tapan Kumar; Mannarapu, Mastan; Alam, Afroz; Basha, Riyaz Mahammad; Bramhachari, Pallaval Veera; Verma, Dheeraj; Sushma, Pinninti Santosh; Pattnaik, Subasini; Nagaraju, Ganji Purnachandra.

In: Critical Reviews in Oncology/Hematology, Vol. 116, 01.08.2017, p. 125-133.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Adiponectin

T2 - Its role in obesity-associated colon and prostate cancers

AU - Muppala, Santoshi

AU - Konduru, Siva K.P.

AU - Merchant, Neha

AU - Ramsoondar, Judy

AU - Rampersad, Carlos Karan

AU - Rajitha, Balney

AU - Mukund, Vidya

AU - Kancherla, Jyothsna

AU - Hammond, Anthea

AU - Barik, Tapan Kumar

AU - Mannarapu, Mastan

AU - Alam, Afroz

AU - Basha, Riyaz Mahammad

AU - Bramhachari, Pallaval Veera

AU - Verma, Dheeraj

AU - Sushma, Pinninti Santosh

AU - Pattnaik, Subasini

AU - Nagaraju, Ganji Purnachandra

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Adipose tissue synthesizes many proteins and hormones collectively called adipokines, which are linked to a number of diseases, including cancer. Low levels of adiponectin are reported to be a risk factor for obesity-related cancers including colorectal and prostate cancers. Accordingly, obesity/lifestyle-related diseases, including certain cancers, may be treated by developing drugs that act specifically on adiponectin levels in circulation. Adiponectin may also serve as a clinical biomarker in obesity-related diseases. Adiponectin-based therapies are known to inhibit cancer advancement and thus may provide a therapeutic approach to delay cancer progression. Better understanding of the function of adiponectin is of great significance in the fight against cancer. This timely review is concentrated on the role of adiponectin and the impact of obesity on the development of cancers, especially colorectal and prostate cancers.

AB - Adipose tissue synthesizes many proteins and hormones collectively called adipokines, which are linked to a number of diseases, including cancer. Low levels of adiponectin are reported to be a risk factor for obesity-related cancers including colorectal and prostate cancers. Accordingly, obesity/lifestyle-related diseases, including certain cancers, may be treated by developing drugs that act specifically on adiponectin levels in circulation. Adiponectin may also serve as a clinical biomarker in obesity-related diseases. Adiponectin-based therapies are known to inhibit cancer advancement and thus may provide a therapeutic approach to delay cancer progression. Better understanding of the function of adiponectin is of great significance in the fight against cancer. This timely review is concentrated on the role of adiponectin and the impact of obesity on the development of cancers, especially colorectal and prostate cancers.

KW - Adiponectin

KW - Adiponectin receptors

KW - Colorectal cancer

KW - Obesity

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85024849369&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2017.06.003

DO - 10.1016/j.critrevonc.2017.06.003

M3 - Review article

VL - 116

SP - 125

EP - 133

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -

Muppala S, Konduru SKP, Merchant N, Ramsoondar J, Rampersad CK, Rajitha B et al. Adiponectin: Its role in obesity-associated colon and prostate cancers. Critical Reviews in Oncology/Hematology. 2017 Aug 1;116:125-133. https://doi.org/10.1016/j.critrevonc.2017.06.003